Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 6/2016

01-06-2016 | Colorectal Cancer

Comparison of Long-Term Outcomes Between Emergency Surgery and Bridge to Surgery for Malignant Obstruction in Right-Sided Colon Cancer: A Multicenter Retrospective Study

Authors: Bong-Hyeon Kye, MD, Yoon Suk Lee, MD, Hyeon-Min Cho, MD, Jun-Gi Kim, MD, Seong-Taek Oh, MD, In Kyu Lee, MD, Won Kyung Kang, MD, Chang-Hyeok Ahn, MD, Sang Chul Lee, MD, Jong-Kyung Park, MD, Hyung-Jin Kim, MD

Published in: Annals of Surgical Oncology | Issue 6/2016

Login to get access

Abstract

Background

Malignant obstruction in right-sided colon (MORC) has traditionally been treated by emergency resection with primary anastomosis. The aim of this study was to evaluate short-term postoperative and long-term oncologic outcomes according to the surgical approach adopted for MORC.

Methods

A total of 1785 patients who underwent curative surgery for stage II or III colon cancer in seven hospitals were reviewed retrospectively. Seventy-four of 1785 patients had MORC. We compared the postoperative outcome and long-term oncologic outcome between the emergency surgery (ES) group (49 patients) and the bridge to surgery (BS) group (25 patients) for 74 patients with MORC.

Results

There were no differences in the length of the distal and proximal resection margin (p = 0.820 and p = 0.620) or the number of metastatic lymph nodes (p = 0.221). There were no differences in flatus passage (p = 0.242), start of diet (p = 0.336), hospital stay (p = 0.444), or postoperative morbidity (p = 0.762). The 5-year overall survival rates were 73.2 % in the ES group and 90.7 % in the BS group (p = 0.172). Moreover, the 5-year disease-free survival rates were 71.9 % in the ES group and 76.2 % in the BS group (p = 0.929).

Conclusions

On the basis of the above results, the postoperative course of the ES group was similar to that of the BS group. In addition, the long-term oncologic outcome of the BS group was similar or slightly better than that of the ES group. BS after colonic stent may be an alternative option for MORC.
Literature
1.
2.
Setti Carraro PG, Segala M, Cesana B, Tiberio G. Obstructing colonic cancer: failure and survival patterns over a ten-year follow-up after one-stage curative surgery. Dis Colon Rectum. 2001;44:243–50.
3.
Carty N, Corder AP. Which surgeons avoid a stoma in treating left-sided colonic obstruction? Results of a postal questionnaire. Ann Coll Surg Engl. 1992;74:391–4.
4.
Fielding LP, Wells BW. Survival after primary and staged resection for large bowel obstruction caused by cancer. Br J Surg. 1974;61:16–8.CrossRefPubMed
5.
Phillips RKS, Hittinger R, Fry JS, Fielding LP. Malignant large bowel obstruction. Br J Surg. 1985;72:296–302.CrossRefPubMed
6.
Repici A, Adler DG, Gibbs CM, et al. Stenting of the proximal colon in patients with malignant large bowel obstruction: techniques and outcomes. Gastrointest Endosc. 2007;66:940–4.CrossRefPubMed
7.
Tekkis PP, Kinsman R, Thompson MR, Stamatakis JD. The Association of Coloproctology of Great Britain and Ireland study of large bowel obstruction caused by colorectal cancer. Ann Surg. 2004;240:76–81.CrossRefPubMedPubMedCentral
8.
Hsu TC. Comparison of one-stage resection and anastomosis of acute complete obstruction of left and right colon. Am J Surg. 2005;189:384–7.CrossRefPubMed
9.
Campbell KL, Hussey JK, Eremin O. Expandable metal stent application in obstructing carcinoma of the proximal colon: report of a case. Dis Colon Rectum. 1997;40:1391–3.CrossRefPubMed
10.
Balague C, Targarona EM, Sainz S, et al. Minimally invasive treatment for obstructive tumors of the left colon: endoluminal self-expanding metal stent and laparoscopic colectomy: preliminary results. Dig Surg. 2004;21:282–6.CrossRefPubMed
11.
Cho YK, Kim SW, Lee BI, et al. Clinical outcome of self-expandable metal stent placement in the management of malignant proximal colon obstruction. Gut Liver. 2011;5:165–70.CrossRefPubMedPubMedCentral
12.
Stimac D. Colonic stents for the palliation of malignant colonic obstruction. Dig Dis. 2008;26:336–41.CrossRefPubMed
13.
Bhardwaj R, Parker MC. Palliative therapy of colorectal carcinoma: stent or surgery? Colorectal Dis. 2003;5:518–21.CrossRefPubMed
14.
Maruthachalam K, Lash GE, Shenton BK, Horgan AF. Tumour cell dissemination following endoscopic stent insertion. Br J Surg. 2007;94:1151–4.CrossRefPubMed
15.
Steinert EM, Schwartz RH, Singh NJ. At low precursor frequencies, the T-cell response to chronic self-antigen results in anergy without deletion. Eur J Immunol. 2012;42:2875–80.CrossRefPubMedPubMedCentral
16.
Sabbagh C, Chatelain D, Trouillet N, et al. Does use of a metallic colon stent as a bridge to surgery modify the pathology data in patients with colonic obstruction? A case-matched study. Surg Endosc. 2013;27:3622–31.CrossRefPubMed
17.
Kim HJ, Choi GS, Park JS, et al. Higher rate of perineural invasion in stent-laparoscopic approach in comparison to emergent open resection for obstructing left-sided colon cancer. Int J Colorectal Dis. 2013;28:407–14.CrossRefPubMed
18.
Saida Y, Sumiyama Y, Nagao J, Uramatsu M. Long-term prognosis of preoperative “bridge to surgery” expandable metallic stent insertion for obstructive colorectal cancer: comparison with emergency operation. Dis Colon Rectum. 2003;46(10 suppl):S44–9.PubMed
19.
Kim JS, Hur H, Min BS, et al. Oncologic outcomes of self-expanding metallic stent insertion as a bridge to surgery in the management of left-sided colon cancer obstruction: comparison with nonobstructing elective surgery. World J Surg. 2009;33:1281–6.CrossRefPubMed
20.
Choi JM, Lee C, Han YM, et al. Long-term oncologic outcomes of endoscopic stenting as a bridge to surgery for malignant colonic obstruction: comparison with emergency surgery. Surg Endosc. 2014;28:2649–55.CrossRefPubMed
21.
Sabbagh C, Browet F, Diouf M, et al. Is stenting as a “bridge to surgery” an oncologically safe strategy for the management of acute, left-sided, malignant, colonic obstruction? A comparative study with a propensity score analysis. Ann Surg. 2013;258:107–15.CrossRefPubMed
Metadata
Title
Comparison of Long-Term Outcomes Between Emergency Surgery and Bridge to Surgery for Malignant Obstruction in Right-Sided Colon Cancer: A Multicenter Retrospective Study
Authors
Bong-Hyeon Kye, MD
Yoon Suk Lee, MD
Hyeon-Min Cho, MD
Jun-Gi Kim, MD
Seong-Taek Oh, MD
In Kyu Lee, MD
Won Kyung Kang, MD
Chang-Hyeok Ahn, MD
Sang Chul Lee, MD
Jong-Kyung Park, MD
Hyung-Jin Kim, MD
Publication date
01-06-2016
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 6/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-015-5053-7

Other articles of this Issue 6/2016

Annals of Surgical Oncology 6/2016 Go to the issue

Gastrointestinal Oncology

Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer

Colorectal Cancer

KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion

Breast Oncology

Asymptomatic Benign Papilloma Without Atypia Diagnosed at Ultrasonography-Guided 14-Gauge Core Needle Biopsy: Which Subgroup can be Managed by Observation?

Breast Oncology

The Search Continues for the Ideal Method to Localize Nonpalpable Breast Lesions

Thoracic Oncology

A Population-Based Cost Analysis of Thoracoscopic Versus Open Lobectomy in Primary Lung Cancer

Thoracic Oncology

Epidermal Growth Factor Receptor Mutation Status and Treatment Outcome for R0-Resected Patients with Stage 3 Non-small Cell Lung Cancer